http://www.nextprot.org/nanopubs#NX_P62805-1_PTM-0237_4.RAVXTHstIsC6-O3H-h66OOqikenCGahN9bO0aHz0rjfuU
type: Nanopublication
created: 2014-09-19T00:00:00.0Z
rights: http://creativecommons.org/licenses/by/3.0/
rights holder: nextprot.org
used data: neXtProt database
authored by: CALIPHO project
authored by: http://orcid.org/0000-0001-6710-1373
authored by: 0000-0001-6818-334X
authored by: http://orcid.org/0000-0002-1303-2189
authored by: http://orcid.org/0000-0003-1813-6857
version number: 2

http://www.nextprot.org/nanopubs#NX_P62805-1_PTM-0237_4.RAVXTHstIsC6-O3H-h66OOqikenCGahN9bO0aHz0rjfuU._2
SIO_000300: 4
type: StartPosition

http://www.nextprot.org/nanopubs#NX_P62805-1_PTM-0237_4.RAVXTHstIsC6-O3H-h66OOqikenCGahN9bO0aHz0rjfuU._3
SIO_000300: 4
type: EndPosition

http://www.nextprot.org/nanopubs#NX_P62805-1_PTM-0237_4.RAVXTHstIsC6-O3H-h66OOqikenCGahN9bO0aHz0rjfuU.assertion
comment: Omega-N-methylarginine; by PRMT1; alternate modification of amino acid 4 of NX_P62805-1
evidence: gold
primary source: science.1060781
primary source: science.1101400
primary source: http://www.ncbi.nlm.nih.gov/pubmed/11387442
primary source: http://www.ncbi.nlm.nih.gov/pubmed/11448779
primary source: http://www.ncbi.nlm.nih.gov/pubmed/15345777

neXtProt gold
type: ECO_0000205